Advertisement

Vascular Manifestations in Alagille Syndrome

  • Shannon M. Vandriel
  • Rebecca N. Ichord
  • Binita M. KamathEmail author
Chapter

Abstract

Non-cardiac vascular anomalies and events are now widely recognized in Alagille syndrome (ALGS) and are a significant cause of morbidity and mortality. Cerebrovascular disorders in ALGS includes cerebral artery aneurysms, moyamoya syndrome, and anomalies of the internal carotid artery. Systemic vascular abnormalities have also been documented. These structural anomalies contribute to but do not fully explain the high incidence of intracranial and systemic bleeding episodes in ALGS. The presence of vascular anomalies in ALGS is consistent with the intrinsic role of the Notch signaling pathway in vascular morphogenesis, angiogenesis, and vessel homeostasis. Given the relatively high prevalence of silent cerebrovascular disease in ALGS, it is becoming accepted that all patients undergo screening imaging with computed tomography scan or magnetic resonance angiography. This is particularly important in those undergoing liver transplantation or major surgery.

Keywords

Alagille syndrome NOTCH signaling pathway Vasculature Cerebral aneurysms Moyamoya syndrome Arterial anastomoses 

References

  1. 1.
    Gridley T. Notch signaling during vascular development. Proc Natl Acad Sci U S A. 2001;98(10):5377–8.CrossRefGoogle Scholar
  2. 2.
    Gridley T. Notch signaling in the vasculature. Curr Top Dev Biol. 2010;92:277–309.CrossRefGoogle Scholar
  3. 3.
    Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134(15):2709–18.CrossRefGoogle Scholar
  4. 4.
    Xue Y, Gao X, Lindsell CE, et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet. 1999;8(5):723–30.CrossRefGoogle Scholar
  5. 5.
    Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000;14(11):1343–52.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Hamada Y, Kadokawa Y, Okabe M, Ikawa M, Coleman JR, Tsujimoto Y. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development. 1999;126(15):3415–24.Google Scholar
  7. 7.
    Pedrosa AR, Trindade A, Fernandes AC, et al. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1. Arterioscler Thromb Vasc Biol. 2015;35(5):1134–46.CrossRefGoogle Scholar
  8. 8.
    Domenga V, Fardoux P, Lacombe P, et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004;18(22):2730–5.CrossRefGoogle Scholar
  9. 9.
    Martignetti JA, Tian L, Li D, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013;92(6):1001–7.CrossRefGoogle Scholar
  10. 10.
    Pippucci T, Maresca A, Magini P, et al. Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy. EMBO Mol Med. 2015;7(6):848–58.CrossRefGoogle Scholar
  11. 11.
    Abou Al-Shaar H, Qadi N, Al-Hamed MH, Meyer BF, Bohlega S. Phenotypic comparison of individuals with homozygous or heterozygous mutation of NOTCH3 in a large CADASIL family. J Neurol Sci. 2016;367:239–43.CrossRefGoogle Scholar
  12. 12.
    Moreau S, Bourdon N, Jokic M, et al. Alagille syndrome with cavernous carotid artery aneurysm. Int J Pediatr Otorhinolaryngol. 1999;50(2):139–43.CrossRefGoogle Scholar
  13. 13.
    Cowan JA Jr, Barkhoudarian G, Yang LJ, Thompson BG. Progression of a posterior communicating artery infundibulum into an aneurysm in a patient with Alagille syndrome. Case report. J Neurosurg. 2004;101(4):694–6.CrossRefGoogle Scholar
  14. 14.
    Schlosser HG, Kerner T, Woiciechowsky C, Benndorf G. Multiple cerebral aneurysms and subarachnoid hemorrhage in a patient with Alagille syndrome. AJNR Am J Neuroradiol. 2004;25(8):1366–7.PubMedGoogle Scholar
  15. 15.
    Tumialan LM, Dhall SS, Tomak PR, Barrow DL. Alagille syndrome and aneurysmal subarachnoid hemorrhage. Case report and review of the literature. Pediatr Neurosurg. 2006;42(1):57–61.CrossRefGoogle Scholar
  16. 16.
    Doberentz E, Kuchelmeister K, Madea B. Subarachnoid hemorrhage due to aneurysm rupture in a young woman with Alagille syndrome - a rare cause of sudden death. Leg Med. 2015;17(5):309–12.CrossRefGoogle Scholar
  17. 17.
    Fiorda-Diaz J, Shabsigh M, Dimitrova G, Soghomonyan S, Sandhu G. Perioperative management of subarachnoid hemorrhage in a patient with Alagille syndrome and unrepaired tetralogy of Fallot: case report. Front Surg. 2017;4:72.CrossRefGoogle Scholar
  18. 18.
    Kamath BM, Spinner NB, Emerick KM, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004;109(11):1354–8.CrossRefGoogle Scholar
  19. 19.
    Kayhan A, Ilkhchoui Y, Venu N, Jensen DM, Oto A. Multiple abdominal vascular anomalies in a patient with Alagille syndrome. J Vasc Interv Radiol. 2010;21(6):937–40.CrossRefGoogle Scholar
  20. 20.
    Connolly HM, Huston J 3rd, Brown RD Jr, Warnes CA, Ammash NM, Tajik AJ. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc. 2003;78(12):1491–9.CrossRefGoogle Scholar
  21. 21.
    Rachmel A, Zeharia A, Neuman-Levin M, Weitz R, Shamir R, Dinari G. Alagille syndrome associated with moyamoya disease. Am J Med Genet. 1989;33(1):89–91.CrossRefGoogle Scholar
  22. 22.
    Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DC, Farrell K. Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. Pediatrics. 1999;103(2):505–8.CrossRefGoogle Scholar
  23. 23.
    Connor SE, Hewes D, Ball C, Jarosz JM. Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst. 2002;18(3–4):186–90.CrossRefGoogle Scholar
  24. 24.
    Emerick KM, Krantz ID, Kamath BM, et al. Intracranial vascular abnormalities in patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2005;41(1):99–107.CrossRefGoogle Scholar
  25. 25.
    Gaba RC, Shah RP, Muskovitz AA, Guzman G, Michals EA. Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome. J Clin Neurosci. 2008;15(12):1395–8.CrossRefGoogle Scholar
  26. 26.
    Pavanello M, Severino M, D'Antiga L, et al. Pretransplant management of basilar artery aneurysm and moyamoya disease in a child with Alagille syndrome. Liver Transpl. 2015;21(9):1227–30.CrossRefGoogle Scholar
  27. 27.
    Rocha R, Soro I, Leitao A, Silva ML, Leao M. Moyamoya vascular pattern in Alagille syndrome. Pediatr Neurol. 2012;47(2):125–8.CrossRefGoogle Scholar
  28. 28.
    Baird LC, Smith ER, Ichord R, et al. Moyamoya syndrome associated with Alagille syndrome: outcome after surgical revascularization. J Pediatr. 2015;166(2):470–3.CrossRefGoogle Scholar
  29. 29.
    Carpenter CD, Linscott LL, Leach JL, Vadivelu S, Abruzzo T. Spectrum of cerebral arterial and venous abnormalities in Alagille syndrome. Pediatr Radiol. 2018;48:602.CrossRefGoogle Scholar
  30. 30.
    Lykavieris P, Crosnier C, Trichet C, Meunier-Rotival M, Hadchouel M. Bleeding tendency in children with Alagille syndrome. Pediatrics. 2003;111(1):167–70.CrossRefGoogle Scholar
  31. 31.
    Berard E, Sarles J, Triolo V, et al. Renovascular hypertension and vascular anomalies in Alagille syndrome. Pediatr Nephrol. 1998;12(2):121–4.CrossRefGoogle Scholar
  32. 32.
    Salem JE, Bruguiere E, Iserin L, Guiochon-Mantel A, Plouin PF. Hypertension and aortorenal disease in Alagille syndrome. J Hypertens. 2012;30(7):1300–6.CrossRefGoogle Scholar
  33. 33.
    Nishikawa A, Mori H, Takahashi M, Ojima A, Shimokawa K, Furuta T. Alagille's syndrome. A case with a hamartomatous nodule of the liver. Acta Pathol Jpn. 1987;37(8):1319–26.PubMedGoogle Scholar
  34. 34.
    Shefler AG, Chan MK, Ostman-Smith I. Middle aortic syndrome in a boy with arteriohepatic dysplasia (Alagille syndrome). Pediatr Cardiol. 1997;18(3):232–4.CrossRefGoogle Scholar
  35. 35.
    Quek SC, Tan L, Quek ST, Yip W, Aw M, Quak SH. Abdominal coarctation and Alagille syndrome. Pediatrics. 2000;106(1):E9.CrossRefGoogle Scholar
  36. 36.
    Hoffenberg EJ, Narkewicz MR, Sondheimer JM, Smith DJ, Silverman A, Sokol RJ. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr. 1995;127(2):220–4.CrossRefGoogle Scholar
  37. 37.
    Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999;29(3):822–9.CrossRefGoogle Scholar
  38. 38.
    Arnon R, Annunziato R, Schiano T, et al. Orthotopic liver transplantation for adults with Alagille syndrome. Clin Transpl. 2012;26(2):E94–E100.CrossRefGoogle Scholar
  39. 39.
    Kamath BM, Yin W, Miller H, et al. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience. Liver Transpl. 2012;18(8):940–8.CrossRefGoogle Scholar
  40. 40.
    Kohaut J, Pommier R, Guerin F, et al. Abdominal arterial anomalies in children with Alagille syndrome: surgical aspects and outcomes of liver transplantation. J Pediatr Gastroenterol Nutr. 2017;64(6):888–91.CrossRefGoogle Scholar
  41. 41.
    Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. 4th ed. Cambridge: Cambridge University Press; 2014. p. 216–33.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Shannon M. Vandriel
    • 1
  • Rebecca N. Ichord
    • 2
  • Binita M. Kamath
    • 1
    • 3
    Email author
  1. 1.Division of Gastroenterology, Hepatology and NutritionThe Hospital for Sick ChildrenTorontoCanada
  2. 2.Division of NeurologyThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  3. 3.Department of PediatricsUniversity of TorontoTorontoCanada

Personalised recommendations